⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3136361 | 0.73 | ALDH1A1 (0.31) | — | |
| SCHEMBL31231126 | 0.67 | — | — | |
| SCHEMBL28072669 | 0.65 | MEN1 (0.35) | — | |
| SCHEMBL37950 | 0.65 | MEN1 (0.35) | — | |
| SCHEMBL3702489 | 0.64 | — | — | |
| SCHEMBL8905910 | 0.63 | — | — | |
| Water SCHEMBL11357123 | 0.62 | APAF1 (0.33) | — | |
| Bromide SCHEMBL28523892 | 0.62 | APAF1 (0.33) | — | |
| SCHEMBL640436 | 0.62 | APAF1 (0.33) | — | |
| Hydrochloric Acid SCHEMBL4647777 | 0.62 | APAF1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4089 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066799-A1 | UNNATURAL BASE PAIR COMPOSITIONS AND METHODS OF USE | THE SCRIPPS RESEARCH INSTITUTE | 2025-02-27 | — | — | US | claimed |
| CN-112105627-B | Unnatural base pair compositions and methods of use | 斯克利普斯研究所 | 2024-07-02 | — | — | CN | claimed |
| CN-117778530-A | Method for adding preset joint to 5' end of single-stranded DNA | 清华大学 | 2024-03-29 | — | — | CN | claimed |
| US-20230235339-A1 | IMPORT OF UNNATURAL OR MODIFIED NUCLEOSIDE TRIPHOSPHATES INTO CELLS VIA NUCLEIC ACID TRIPHOSPHATE TRANSPORTERS | THE SCRIPPS RESEARCH INSTITUTE | 2023-07-27 | — | — | US | claimed |
| EP-4041249-A1 | COMPOSITIONS AND METHODS FOR IN VIVO SYNTHESIS OF UNNATURAL POLYPEPTIDES | The Scripps Research Institute (US) | 2022-08-17 | — | — | EP | claimed |
| US-20220243244-A1 | COMPOSITIONS AND METHODS FOR IN VIVO SYNTHESIS OF UNNATURAL POLYPEPTIDES | NATIONAL INSTITUTES OF HEALTH | 2022-08-04 | — | — | US | claimed |
| CN-114761026-A | Compositions and methods for in vivo synthesis of non-native polypeptides | 斯克利普斯研究所 | 2022-07-15 | — | — | CN | claimed |
| WO-2021072167-A1 | COMPOSITIONS AND METHODS FOR IN VIVO SYNTHESIS OF UNNATURAL POLYPEPTIDES | THE SCRIPPS RESEARCH INSTITUTE (US) | 2021-04-15 | — | — | WO | claimed |
| EP-3732187-A1 | UNNATURAL BASE PAIR COMPOSITIONS AND METHODS OF USE | The Scripps Research Institute (US) | 2020-11-04 | — | — | EP | claimed |
| US-20200318122-A1 | UNNATURAL BASE PAIR COMPOSITIONS AND METHODS OF USE | THE SCRIPPS RESEARCH INSTITUTE | 2020-10-08 | — | — | US | claimed |
| US-7666854-B2 | Bis-modified bicyclic nucleic acid analogs | ISIS PHARMACEUTICALS, INC. (US) | 2010-02-23 | — | — | US | claimed |
| WO-2009124238-A1 | OLIGOMERIC COMPOUNDS COMPRISING NEUTRALLY LINKED TERMINAL BICYCLIC NUCLEOSIDES | ISIS PHARMACEUTICALS, INC. (US) | 2009-10-08 | — | — | WO | claimed |
| WO-2009117589-A1 | OLIGOMERIC COMPOUNDS COMPRISING TRICYCLIC NUCLEOSIDES AND METHODS FOR THEIR USE | ISIS PHARMACEUTICALS, INC. (US) | 2009-09-24 | — | — | WO | claimed |
| WO-2009100320-A2 | BICYCLIC CYCLOHEXITOL NUCLEIC ACID ANALOGS | ISIS PHARMACEUTICALS, INC. (US) | 2009-08-13 | — | — | WO | claimed |
| US-20090156792-A1 | BIS-MODIFIED BICYCLIC NUCLEIC ACID ANALOGS | IONIS PHARMACEUTICALS, INC. | 2009-06-18 | — | — | US | claimed |
| WO-2009067647-A1 | CARBOCYCLIC ALPHA-L-BICYCLIC NUCLEIC ACID ANALOGS | ISIS PHARMACEUTICALS, INC. (US) | 2009-05-28 | — | — | WO | claimed |
| US-20090092981-A1 | TETRAHYDROPYRAN NUCLEIC ACID ANALOGS | IONIS PHARMACEUTICALS, INC. | 2009-04-09 | — | — | US | claimed |
| WO-2009023855-A2 | TETRAHYDROPYRAN NUCLEIC ACID ANALOGS | ISIS PHARMACEUTICALS, INC. (US) | 2009-02-19 | — | — | WO | claimed |
| WO-2008150729-A2 | N-SUBSTITUTED-AMINOMETHYLENE BRIDGED BICYCLIC NUCLEIC ACID ANALOGS | ISIS PHARMACEUTICALS, INC. (US) | 2008-12-11 | — | — | WO | claimed |
| US-7067497-B2 | Modulation of telomere length by oligonucleotides having a G-core sequence | ISIS PHARMACEUTICALS, INC. (US) | 2006-06-27 | — | — | US | claimed |